JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M110309200 on February 20, 2002

J. Biol. Chem., Vol. 277, Issue 18, 15400-15406, May 3, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/18/15400    most recent
M110309200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leach, J. K.
Right arrow Articles by Mikkelsen, R. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leach, J. K.
Right arrow Articles by Mikkelsen, R. B.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Activation of Constitutive Nitric-oxide Synthase Activity Is an Early Signaling Event Induced by Ionizing Radiation*

J. Kevin LeachDagger §, Stephen M. Black||, Rupert K. Schmidt-UllrichDagger , and Ross B. MikkelsenDagger **

From the Dagger  Department of Radiation Oncology, Virginia Commonwealth University, Richmond, Virginia 23298-0058 and the  Division of Neonatology, Northwestern University, Chicago, Illinois 60611-3008

Received for publication, October 26, 2001, and in revised form, January 31, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Ionizing radiation at clinical dose levels activates both pro- and anti-proliferative signal transduction pathways, the balance of which determines cell fate. The initiating and amplifying mechanisms involved in the activation are poorly understood. We demonstrate that one mechanism involves stimulation of constitutive nitric-oxide synthase (NOS) activity. NOS activity of Chinese hamster ovary cells was measured by the arginine right-arrow citrulline conversion assay. Irradiation stimulated a transient activation of NOS with maximal activity at 5 min of post-irradiation. Western blot analysis and genetic manipulation by overexpression of wild type or dominant negative NOS mutant identify the radiation-induced isoform as NOS-1. Further evidence that NOS-1 is activated by radiation was the demonstration of radiation-induced cGMP formation in cells transiently transfected with the NO-dependent soluble guanylate cyclase. Protein Tyr nitration, a footprint of peroxynitrite formation, followed radiation exposure and was inhibited by expression of a dominant negative NOS-1 mutant. Radiation-induced ERK1/2 kinase activity, a cytoprotective response to radiation, was also blocked by inhibiting NOS activity. These experiments establish NO-dependent signal transduction pathways as being radioresponsive. Given the lipophilic and relatively stable properties of NO, these results also suggest a possible mechanism by which ionization events in one cell may activate signaling processes in adjacent cells.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Ionizing radiation activates several cytoplasmic signal transduction pathways involving Tyr kinases, protein kinase C, ERK-1/2,1 ceramide, and Ca2+ homeostatic mechanisms (1-8). Because these pathways represent both pro- and anti-proliferative signals, their relative balance can determine cell fate (2). The underlying mechanisms by which cytoplasmic ionization events initiate these pathways are not known. There are only a few primary ionization events (approx 2000/Gy/cell) implicating sensitive detecting and amplifying mechanisms. Theoretical calculations rule out secondary products of the initial ionization events (e.g. H2O2 and O<UP><SUB>2</SUB><SUP>&cjs1138;</SUP></UP>) because the amount formed at clinical radiation doses (1-5 Gy) is much less than that generated by cellular metabolism (14). Recent studies, however, are consistent with amplification mechanisms responsive to low doses of ionizing radiation and involving ROS or RNS (15-17).

In our studies cellular ROS was measured with dihydro-DCF at the single cell level by fluorescence microscopy (15). ROS generation occurred within seconds of radiation exposure (1-10 Gy) and persisted for 2-5 min post-radiation. The amount of ROS generated per responding cell was relatively constant in this dose range. With increasing radiation dose there was a corresponding increase in number of cells generating elevated ROS, suggesting an all-or-nothing response. Genetic and pharmacological analyses indicated that the radiation-induced ROS resulted from the Ca2+-dependent propagation of a reversible permeability transition from one mitochondrion to another. A similar mechanism for enhanced ROS generation resulting from a reversible permeability transition has been described for cardiomyocytes (18).

RNS may also have a significant role in the response of cells to radiation. NO reacts with O<UP><SUB>2</SUB><SUP>&cjs1138;</SUP></UP> at diffusion controlled rates competing with endogenous SOD for substrate (19). Inhibiting NOS activity or treating cells with NO scavengers stimulates oxidative stress (20-22). The product of O<UP><SUB>2</SUB><SUP>&cjs1138;</SUP></UP> + NO, ONOO-, mostly rearranges to form biologically inert nitrite or reacts with GSH to form the NO donor GSNO (19, 23, 24). However, when the [NO] approaches that of SOD, the resulting high levels of ONOO- produce a number of cell-damaging effects (19, 24). Thus, radiosensitization is observed with exogenous NO donors or after cytokine stimulation of inducible NOS (NOS-2) expression (e.g. Refs. 25 and 26). A cellular footprint of ONOO- formation is the Tyr nitration of proteins (19, 27).

NO is formed during the NOS-catalyzed conversion of arginine to citrulline. Three isoforms of NOS with similar catalytic mechanisms have been described (28). The NOS-1 and -3 isoforms are constitutively expressed in many cell types, and their activities are Ca2+/calmodulin-dependent. NOS-1 and -3 produce relatively low amounts of NO compared with inducible NOS-2. NOS-2 tightly binds calmodulin, and its activity is largely Ca2+-independent. Here we demonstrate that low doses of radiation transiently activate NOS-1. Previous conclusions about radiation-induced ROS based on the use of DCF fluorescence measurements must be modified to include RNS and RNS-dependent downstream signaling.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Cells and Cell Culture-- The CHO-K1 cells were grown in RPMI 1640 plus 5% fetal bovine serum and antibiotics. Cells were transfected with the LipofectAMINE PLUSTM kit (Invitrogen) according to the manufacturer's directions.

Reagents-- Reagents and their suppliers are as follows: fluorescent probes (Molecular Probes, Eugene, OR); anti-nitro-Tyr antibodies (Upstate Biochemicals, Inc., Lake Placid, NY); anti-Mn-SOD antibody (Oxis Biochemical, CA); anti-ERK1/2, anti-Myc, anti-SHP-1, and anti-SHP-2 antibody (Santa Cruz Biotechnology, Santa Cruz, CA); secondary antibodies conjugated to alkaline phosphatase (Promega, Madison, WI); and [3H]arginine (ICN Biochemical). Plasmids for rat brain wild type (pnNOS) or dominant negative NOS-1 mutants (pHeme-RedF and pHeme) have been described (29). Plasmids encoding the alpha - and beta -subunits of sGC were provided by Dr. P. Yuen (30). Dr. C. Susini provided the pSHP-1 wild type and pSHP-1c/s plasmids. The latter Cys453 right-arrow Ser mutant is catalytically inactive and behaves as a dominant negative mutant (31). The corresponding plasmids encoding Myc-tagged wild type and the Cys459 right-arrow Ser dominant negative SHP-2 mutant were obtained from Dr. J. Pessin (32).

Determination of NOS Activity of Intact Cells-- Subconfluent CHO-K1 cells in 35-mm culture dishes were incubated for 20 min at 37 °C in 145 mM NaCl, 5 mM KCl, 1 mM MgSO4, 1 mM CaCl2, 10 mM Hepes (pH 7.4), 5 mM glucose, and 15 mM D-valine. D-Valine was included to inhibit cellular arginase. [3H]Arginine (1.5 µCi/ml) was added for an additional 20 min. After irradiation, culture medium was aspirated, and culture dishes were snap-frozen on dry ice at the indicated times. Cells were scraped into 25 mM Hepes (pH 5.5), 5 mM EDTA, 5 mM EGTA, 10 mM citrulline, sonicated, and cell lysates clarified by micro-centrifugation for 10 min at 4 °C. The supernatant was mixed with 0.5 ml of 50% Dowex AG 50-WX8 (Na+ form) equilibrated with the above buffer to complex non-reacted arginine. After a short micro-centrifugation, radioactivity of the eluate ([3H]citrulline) was determined by scintillation counting.

ROS/RNS Production-- Single cell analysis with a digitized imaging system, radiation with a 90Sr source mounted on the microscope, and dye loading conditions have been described (1, 15). Dihydro-DCF, which becomes fluorescent upon oxidation, is a well characterized dye for detecting ROS/RNS (15, 16, 33-35). The spectroscopic properties of DCF (excitation at 490 nm, emission at 530 nm) do not permit ratiometric analysis and normalization for the sampling volume. To achieve the latter, cells were simultaneously loaded with fura-2, a Ca2+-sensitive dye, and fura-2 fluorescence was monitored at 530 nm with excitation at 360 nm, the Ca2+-insensitive, isosbestic excitation wavelength of fura-2 (15).

Immunoprecipitation/Western Blot Analyses-- Cells from confluent 6-cm dishes were washed once with ice-cold phosphate-buffered saline and scraped into 300 µl of lysis buffer (150 mM NaCl, 1.0% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris-HCl (pH 8.0)). Lysates were incubated overnight with 1 µg of precipitating antibody followed by incubation for 1 h with protein G plus agarose beads (Calbiochem). Beads were washed once in lysis buffer and twice in phosphate-buffered saline before boiling for 5 min in SDS sample buffer. Proteins were analyzed by standard Western blotting methods (7). Where quantitation was indicated, the radiograms were scanned and densities determined with Jandel SigmaScan software.

cGMP Measurements-- Cells in 35-mm dishes were transfected with equal amounts (0.5 µg) of plasmids encoding the alpha - and beta -subunits of sGC. Forty eight h after transfection cells were incubated for 30 min with 0.6 mM 3-isobutyl-1-methylxanthine to inhibit phosphodiesterases and irradiated with 3 Gy. At the designated times, culture medium was aspirated, and cells were lysed with 300 µl of 0.1 M HCl. cGMP levels in the lysates were measured with the non-acetylated version of a competitive ELISA assay kit (Biomol, Plymouth Meeting, PA).

ERK1/2 Kinase Activity-- An immune complex kinase assay with myelin basic protein as substrate was used to measure ERK1/2 kinase activity (7). Activation of ERK1/2 was also assessed by Western blots of cellular lysates with antibody specific for the phosphorylated, activated forms of the kinases (anti-phospho-p44/42 E10 monoclonal antibody, Cell Signaling Technology, Beverly, MA). Procedures followed the manufacturer's protocol with cell lysates prepared from confluent 35-mm cell cultures.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Radiation Stimulates NOS-1 Activity in Epithelial Cells-- CHO-K1 cells were irradiated at a clinically representative dose of 2 Gy. NOS activities were assessed at the indicated post-irradiation times by the amount of [3H]citrulline formed and retained in both irradiated and sham-irradiated cells. In the non-irradiated cells, the amount of cell associated [3H]citrulline was constant over the 30-min period investigated. However, in cells exposed to radiation, NOS activity (cell associated citrulline) was transiently enhanced with a maximal fold activation of 1.58 ± 0.11 at 5 min post-irradiation (Fig. 1A). By 10 min after radiation the fold activation had decreased to 1.33 ± 0.08 compared with non-irradiated samples. By 30 min, NOS activity had returned to basal levels.


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 1.   Radiation activates NOS-1 in CHO-K1 cells. NOS activity was measured by the arginine right-arrow citrulline conversion assay as described in the text. Radiation dose was 2 Gy, and t = 0 was designated as the end of the radiation period. A, cells were pre-equilibrated with 1 mM L-NMMA 60 min prior to radiation. , control; open circle , + L-NMMA. B, cells were transfected as described under "Experimental Procedures." Cells were irradiated 48 h post-transfection. The results represent the average ± S.E. of 3 independent experiments except for the identical controls. The controls (19 independent experiments) are identical in both panels and are a summation of controls from empty vector-transfected and non-transfected cells. There was no statistical difference between the two. , Control; open circle , pHeme-RedF; black-down-triangle , pnNOS. Inset shows a Western blot analysis of lysates from transfected cells (approx 20 µg for pHeme-RedF and pnNOS-transfected cells and approx 40 µg for vector control).

Both pharmacological and genetic approaches were used to establish further this assay of cellular NOS activity. L-NMMA is a competitive inhibitor of all three NOS isoforms. As shown in Fig. 1A incubating cells for 60 min prior to radiation with 1 mM L-NMMA inhibited radiation-induced NOS activity by more than 50%. Basal activity was equally inhibited by this treatment. Another NOS inhibitor, NG-nitro-L-arginine, also inhibited basal and radiation-stimulated NOS activity (data not shown).

Previous studies (36) demonstrated that CHO-K1 cells express NOS-1. Thus we tested whether we could manipulate basal and radiation-induced NOS activities by overexpression of wild type NOS-1 or expression of a dominant negative mutant. CHO-K1 cells were transfected with expression plasmids encoding wild type rat brain NOS-1 (pnNOS) or a dominant negative NOS-1 mutant (pHeme-RedF). The mutant protein encoded by pHeme-RedF prevents dimerization of endogenous NOS-1 monomers and thus inhibits NOS-1 activity (29). Relative expression levels of the wild type and mutant proteins detected by Western blot are shown in the inset to Fig. 1B. In the vector-control cells a band that migrates with the same mobility as wild type rat brain NOS-1 is just detectable relative to cells transfected with either pnNOS or pHeme-RedF. Immunoreactivity of this band is inhibited by the peptide used to generate the NOS-1 antibody and is also reactive with other anti-NOS-1 antibodies but not antibodies directed against either NOS-2 or NOS-3 (data not shown).

Basal NOS activity of cells overexpressing wild type NOS-1 was not significantly different from vector control cells. However, radiation-stimulated NOS activity was enhanced in the NOS-1-overexpressing cells. In contrast, expression of the dominant negative NOS-1 mutant protein reduced basal NOS activity by 35 ± 3% and almost completely inhibited radiation-stimulated activity (Fig. 1B). Similar results were obtained with another dominant negative NOS-1 expression plasmid, pHeme (see Ref. 29 and data not shown).

To judge the relative quantitative significance of these radiation-induced changes in cellular NOS-1 activity, we compared the fold activation obtained with radiation with that observed after increasing intracellular [Ca2+]. Cells were treated with the Ca2+ ionophore, ionomycin, to maximally elevate intracellular [Ca2+] or with ATP to activate purinergic receptors and as a consequence stimulate a transient increase in cytosolic [Ca2+].2 Incubating cells with 10 µM ionomycin or 400 nM ATP for 5 min caused 3.3 ± 0.3- and 1.5 ± 0.2-fold, respectively, increases in NOS activity (n = 3 independent experiments). These increases in NOS activity are comparable with those obtained with the radiation doses used here.

A previous study (36) reported that in CHO-K1 cells the protein-Tyr phosphatase, SHP-2, was capable of dephosphorylating and as a consequence activating NOS-1. We tested for a potential role for SHP-2 in radiation-mediated NOS-1 activation. NOS activity was measured by the arginine-citrulline conversion assay with CHO-K1 cells transiently transfected with plasmids encoding either wild type SHP-2 or the dominant negative Cys459 right-arrow Ser SHP-2 mutant (32). Results in Fig. 2A show that expression of the Cys459 right-arrow Ser SHP-2 mutant like the dominant negative NOS-1 mutant almost completely suppresses radiation-induced NOS activity. Overexpression of wild type SHP-2, on the other hand, further enhanced the observed stimulation of NOS activity by radiation (2.64 ± 0.66 versus 1.55 ± 0.05). This enhancement in the radiation response was similar to that observed with cells overexpressing wild type NOS-1. The results from experiments with wild type SHP-2 and Cys459 right-arrow Ser SHP-2 mutant expression parallel those obtained in previous studies (36). Similar experiments have also been performed with the wild type SHP-1 and Cys459 right-arrow Ser dominant negative SHP-1 mutant, but the expression of either protein had no effect on radiation-stimulated NOS activity (Fig. 2B). We also tested whether NOS-1 in CHO-K1 cells was Tyr-phosphorylated as reported previously (36). Multiple attempts with different antibodies directed against phospho-Tyr and with or without immunoprecipitation of NOS-1 were unsuccessful in demonstrating Tyr-phosphorylated NOS-1. Treatment of cells with 1 mM orthovanadate, a Tyr phosphatase inhibitor, for up to 1 h also did not alter the phosphorylation status of NOS-1. These results suggest that some other protein whose activity is modulated by SHP-2 is required for regulating NOS-1 activity after a radiation exposure.


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 2.   Radiation-induced NOS activity is modulated by the Tyr phosphatase, SHP-2. A, cells were transfected with plasmids encoding SHP-2 wild type (black-down-triangle ) and dominant negative Cys right-arrow Ser (C/S) SHP-2 mutant (open circle ), and 48 h post-transfection, cells were irradiated (2 Gy) and NOS activities measured with the arginine right-arrow citrulline conversion assay and compared with vector controls (). The results are the average of triplicate samples ±S.E. of one experiment that is representative of two independent experiments. B, identical experiments except that cells were transfected with plasmids encoding SHP-1 wild type (black-down-triangle ) and dominant negative Cys right-arrow Ser (C/S) SHP-1 mutant (open circle ) and compared with vector controls (). The results are the average of triplicate samples ± S.E. of one experiment representative of two independent experiments.

Ionizing Radiation Enhances Cellular cGMP Formation-- An important downstream target of NO is the heme-containing sGC. Activation of sGC is therefore an indicator of NO formation. Because we were unable to detect cGMP in CHO-K1 cells even with a highly sensitive acetylation version of the ELISA kit for cGMP, cells were transfected with expression plasmids encoding the alpha - and beta -subunits of sGC. Forty eight h after transfection and 20 min prior to irradiation, cells were incubated with the cAMP/cGMP phosphodiesterase inhibitor, 3-isobutyl-1-methylxanthine. Cells were irradiated at 3 Gy; cell lysates were prepared at the indicated time points, and cGMP was measured by a competitive ELISA kit. The data (Fig. 3) show that cGMP levels increase with time following a radiation exposure. Control experiments with cells expressing either the alpha - or beta -subunit alone were negative demonstrating that particulate guanylate cyclase was not activated by radiation.


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 3.   Radiation activates soluble guanylate cyclase. CHO cells were transfected with both the alpha - and beta -subunits of sGC. 48 h post-transfection cells were incubated for 20 min with 0.6 mM 3-isobutyl-1-methylxanthine to inhibit cyclic nucleotide phosphodiesterases and then irradiated at 3 Gy (). Control non-irradiated cells were otherwise treated identically (open circle ). Cell lysates were prepared and cGMP measured as described under "Experimental Procedures." The results are the average of duplicate samples ± S.E. from one experiment and are representative of two independent experiments. Cells transfected with either vector alone or with an empty vector contained no measurable cGMP.

Radiation Causes an Increase in RNS in CHO-K1 Cells-- Recent investigations (15-17) using dihydro-DCF as an indicator dye have argued that radiation stimulates ROS generation. Our studies demonstrated that the underlying mechanism involved in part a propagating reversible mitochondrial permeability transition. However, dihydro-DCF is oxidized not only by OH· or H2O2 in the presence of peroxidase but also by ONOO- (34, 35). ONOO- is a reaction product of O<UP><SUB>2</SUB><SUP>&cjs1138;</SUP></UP> and NO and an indicator of cellular NOS activity. To test whether our previous investigations with dihydro-DCF were in fact measuring ONOO-, we repeated these experiments with and without different NOS inhibitors. As before, digitized fluorescence microscopy was employed permitting single cell analysis. Typical results (averaged over all the radio-responsive cells within the microscopic field) are shown in Fig. 4. The initial increase in DCF fluorescence representing oxidation of dihydro-DCF is due to basal mitochondrial electron transport (15). The radiation source is lowered to a fixed position just above the cells initiating a radiation exposure of 1 Gy/10 s. This is accompanied by enhanced rate of DCF fluorescence that is transient, lasting for 3-5 min before returning to the basal rate of increase (15). H2O2 is added where indicated as a positive control. This same experiment was repeated with cells preincubated with NOS inhibitors. The stereospecific inhibitor L-NAME completely inhibited radiation-induced oxidation of dihydro-DCF-oxidizing species, whereas the inactive stereoisomer, D-NAME, was without effect. L-NMMA, another competitive inhibitor of NOS, was also effective at inhibiting radiation-induced dihydro-DCF oxidation (data not shown). These results demonstrate that the radiation-induced oxidation of dihydro-DCF requires NOS activity and that the likely oxidant measured is ONOO-.


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 4.   NOS inhibitors block radiation-induced ROS/RNS generation detected by DCF fluorescence. Experimental details are provided under "Experimental Procedures." A, the results represent the average ±S.E. of the 6 cells responding (out of 20 total in the field) to radiation (4 Gy). B, no cells exhibited enhanced DCF fluorescence after the radiation exposure and thus the results represent the average ± S.E. for all 20 cells sampled in this experiment. B, cells were pre-equilibrated with 1 mM L-NAME for 20 min prior to radiation (4 Gy). H2O2 was added where indicated to 100 µM as a positive control. Results are from one experiment representative of 2 independent experiments.

Protein Tyr Nitration Increases After Radiation-- Protein nitro-Tyr formation is considered to be a marker of ONOO- formation. Protein Tyr nitration was monitored by immunoprecipitation with mouse monoclonal anti-nitro-Tyr followed by immunoblotting with rabbit polyclonal anti-nitro-Tyr. Fig. 5A shows a time course in CHO-K1 cells for protein Tyr nitration after radiation. The protein nitro-Tyr levels of several proteins are transiently increased with maximal Tyr nitration at 5 min post-irradiation. Enhanced protein Tyr nitration after radiation treatment was also observed in a number of other cell lines including RAT-1 fibroblast, U87 glioma, HEK293, and A431 squamous carcinoma cells.


View larger version (71K):
[in this window]
[in a new window]
 
Fig. 5.   Radiation stimulates protein Tyr nitration. A, cell lysates from irradiated CHO-K1 cells were incubated overnight with polyclonal anti-nitro-Tyr. Immunoprecipitates were fractionated by SDS-gel electrophoresis and Western blots probed with monoclonal anti-nitro-Tyr. Radiation dose was 2 Gy. B, cell lysates from 10-cm dishes were prepared either before irradiation (t = 0 min) or 5 min post-irradiation. Lysates were divided into three sets of aliquots as follows: one set included 10 mM 3-nitro-L-Tyr ethyl ester in the immunoprecipitation buffer (lanes 1 and 2), one set were controls (lanes 3 and 4), and the final set included 10 mM 3-nitro-L-Tyr ethyl ester in the Western blot buffer with the primary antibody. C, anti-nitro-Tyr immunoprecipitates were probed with anti-Mn-SOD. D, vector control cells or cells transfected with the dominant negative NOS-1 mutant (pHeme-RedF) were irradiated and cell lysates prepared either before irradiation or 5 min post-irradiation (2 Gy). Anti-nitro-Tyr immunoprecipitates were obtained, electrophoretically fractionated, and Western blots probed with anti-Mn-SOD. For all panels the results presented in each blot have been reproduced in at least two independent experiments.

Control experiments (Fig. 5B) with inclusion of competing 10 mM 3-nitro-Tyr ethyl ester in with the immunoprecipitation or Western blot antibodies established the specificity of the antibodies for our cell system (37). Although 3-nitro-Tyr ethyl ester was an effective inhibitor of the immunoprecipitation of Tyr-nitrated proteins, inhibition was incomplete as observed by the developers of these antibodies (27). This contrasts with the complete inhibition in the Western blot analysis and probably reflects the relative differences in the antibody affinities and antigen presentation as discussed previously (27).

A previous study (37) demonstrated that Mn-SOD, a mitochondrial enzyme, is Tyr-nitrated during ischemia reperfusion. Thus, we tested whether Mn-SOD is nitrated following irradiation (Fig. 5C). At the indicated times post-irradiation nitro-Tyr-labeled proteins were immunoprecipitated, fractionated by gel electrophoresis, and resulting blots probed with anti-Mn-SOD. A single band at 26 kDa was revealed, the intensity of which increased and decreased as described with the other proteins. To show that this nitration of Mn-SOD is the result of radiation-induced NOS activity, similar experiments were performed with cells expressing the dominant negative NOS-1 mutant, Heme-RedF. As shown in Fig. 5D, the radiation-induced Tyr nitration of Mn-SOD is decreased by greater than 50% in the Heme-RedF-expressing cells compared with vector controls. Radiation-stimulated Tyr nitration of Mn-SOD was also inhibited by the NOS inhibitor L-NMMA (data not shown).

Radiation Stimulates ERK1/2 by a NO-dependent Mechanism-- An early consequence of irradiation shown in several cell types is the activation of ERK1/2 kinases (3, 5-7, 37). In cells where it has been examined, the radiation-dependent activation requires Ca2+ and an intact mitochondrial electron transport chain (7, 15). As do other cells, CHO-K1 cells exhibit a transient ERK1/2 activation centered at 3-5 min after radiation and returning to basal levels by 10 min post-irradiation (Fig. 6A). Results in this figure also show that ERK1/2 stimulation is almost completely inhibited when cells are treated with the NOS inhibitor L-NAME. In contrast the ineffective stereoisomer D-NAME does not block radiation-induced increases in ERK1/2 activity. 2-(4-Carboxyphenyl)-4,5-dihydro-4,4,5,5-tetramethyl-1H-imidazol-1-oxy-3-oxide, a scavenger of NO (21), also prevents stimulation of ERK1/2 activity, further establishing a role for NO in the radiation-stimulated ERK1/2 activity (Fig. 6B). In an effort to determine whether NO directly activates ERK1/2 or if ONOO- is involved in the activation of ERK1/2, we incubated the cells with a SOD mimetic, Mn-TBAP (21). Fig. 6B shows that Mn-TBAP abrogates ERK1/2 activation and implicates ONOO- in the activation of ERK1/2.


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 6.   ERK1/2 activation by radiation is blocked by inhibiting NOS activity and NO scavengers. A and B, ERK1/2 activity of CHO-K1 cells was measured by the immune complex assay described under "Experimental Procedures" before (t = 0) and after exposing cells to a radiation dose of 2 Gy. A, cells were pre-incubated for 30 min with either 1 mM L-NAME (black-down-triangle ) or the inactive stereoisomer D-NAME (open circle ) prior to radiation. , untreated, irradiated control cells. B, cells were pre-incubated for 1 h with 100 µM of either the NO scavenger, 2-(4- carboxyphenyl)-4,5-dihydro-4,4,5,5-tetramethyl-1H-imidazol-1-oxy-3-oxide (carboxy-PTIO) (open circle ), or the SOD mimetic, MnTBAP (black-down-triangle ), prior to radiation. , untreated, irradiated control cells. The results in both A and B represent the average ± S.E. of three independent experiments. C, ERK1/2 activity was assessed by Western blotting of cellular lysates with monoclonal antibody directed against the phosphorylated activated forms of ERK1/2. Cells were transfected as described under "Experimental Procedures," and 48 h later, cells were irradiated at 2 Gy. Cell lysates were prepared at the given time points post-irradiation, and equal amounts of protein were loaded per lane. These results are from one experiment representative of three independent experiments.

Results from these NOS inhibitor studies were confirmed in analyses with cells expressing the dominant negative NOS-1 mutant or overexpressing wild type NOS-1. Activation of ERK1/2 was determined by Western blot analysis of lysates with monoclonal antibody specific for the phospho-activated forms of ERK1/2 (Fig. 6C). Overexpression of the wild type NOS-1 had no significant effect on basal or radiation-induced ERK1/2 activation. Expression of the dominant negative NOS-1 mutant, pHeme-RedF, was also without effect on basal ERK1/2 activity. However, pHeme-RedF expression inhibited radiation-induced activity by more than 50% in three independent experiments. This substantial but incomplete inhibition compared with that obtained with small molecule inhibitors probably reflects the less than 100% transfection efficiency (82 ± 16%, n = 5 independent experiments with a green fluorescent protein expressing plasmid). In addition, complete inhibition of NOS-1 activity may not be achieved with cells expressing low levels of the dominant negative mutant.

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Previous studies (15-17, 38) have demonstrated that radiation stimulates metabolic ROS/RNS generation, a possible mechanism by which cells sense and amplify cellular ionization events. Evidence presented herein indicates that one component of this mechanism is a constitutive NOS. Both basal and radiation-induced NOS activities of CHO-K1 cells could be manipulated genetically or pharmacologically in a manner consistent with radiation-stimulating NOS-1. The degree of activation obtained with radiation compared favorably with that observed after treating cells with a Ca2+ ionophore or a purinergic receptor agonist. Downstream consequences of NO generation were assayed. We determined that radiation activated NO-dependent sGC in a time frame consistent with the measurements of NOS activity. In addition, radiation exposure also enhanced protein Tyr nitration, a footprint of ONOO- formation. For one protein examined in detail, radiation-induced Tyr nitration of Mn-SOD was inhibited by NOS inhibitors or by expression of a dominant negative NOS-1 mutant. The combined results demonstrate that ionizing radiation at doses of clinical relevance activate NOS-1.

The mechanistic relationship between the radiation-induced reversible mitochondrial permeability transition described previously (15) and NOS-1 activation is unclear. One possibility lies in localized Ca2+ transients that propagate the permeability transition and can simultaneously activate the Ca2+-dependent NOS-1. This mechanism is supported by the recent finding that NOS-1 can associate with mitochondria via its PDZ domain (39) putting NOS-1 at the origin of mitochondria-released Ca2+. Possibly also involved in this process is the ROS-induced ROS release that accompanies the mitochondrial permeability transition and that may be necessary for its propagation at least in cardiomyocytes (18). Previous studies (36) and results presented here also demonstrate that the protein-Tyr phosphatase SHP-2 modulates NOS-1 activity (Fig. 2). Overexpression of wild type SHP-2 enhances whereas the dominant negative SHP-2 mutant blocks radiation-stimulated NOS activity. This appears counterintuitive because ROS and RNS inhibit Tyr phosphatases (e.g. Ref. 40), and one would predict that ROS generated by radiation or metabolism would inhibit SHP-2 and thus NOS-1. Ongoing studies are attempting to resolve the role of SHP-2 in radiation-induced NOS-1 activation.

NO is the prototypic redox signaling molecule being more versatile than either O<UP><SUB>2</SUB><SUP>&cjs1138;</SUP></UP> or H2O2 (e.g. Refs. 19, 41, and 42). The best described NO-dependent signal transduction pathway involves sGC and the cGMP-dependent PKG. The role of this pathway in the radiation biology of mammalian cells is not known because most cells cultured in vitro do not express key components of this pathway (Refs. 43-47, e.g. sGC for CHO-K1 cells). However, PKG modulates signaling pathways activated by radiation including ERK1/2, p38, and c-Jun NH2-terminal kinase (43-48) and the transcriptional regulation of proteins whose expression is radio-responsive (e.g. c-Fos and p21Waf1, see Refs. 46, 49, and 50). Future in vivo studies of these signaling pathways will need to consider the role of NO-activated PKG.

RNS also induce a number of reversible protein thiol modifications including S-nitrosylation and formation of sulfenic acids and both intramolecular (S-S) and mixed (S-SR, e.g. glutathiolation) disulfides (41, 51). This of special importance to radiation-induced activation of ERK1/2 which we have shown is RNS-dependent (Fig. 6). Both positive and negative regulatory components of ERK1/2 are potentially involved. The GTP exchange activity of Ras is enhanced by nitrosylation of Cys118 resulting in enhanced downstream signaling and ERK1/2 activity (52, 53). On the other hand by dephosphorylating ERK1/2, protein-Tyr phosphatases inhibit ERK1/2 activation. The catalytic sites of protein-Tyr phosphatases are characterized by a Cys within a consensus motif for S-nitrosylation (54). Oxidation of this Cys inhibits phosphatase activity (40). Thus S-nitrosylation of either Ras or a protein-Tyr phosphatase could result in the enhanced ERK1/2 activity observed after radiation. We are investigating both as mechanisms for the radiation-induced modulation of Tyr kinase-dependent pathways including ERK1/2.

Radiation-induced protein Tyr nitration of several proteins is also observed, but its functional significance is unclear (Fig. 5). In the case of Mn-SOD, high concentrations of ONOO- catalyze nitration on Tyr34 (9) resulting in inactivation. However, results from an in-gel assay for Mn-SOD activity did not indicate an effect of radiation on Mn-SOD activity in the time and dose ranges studied here (data not shown). Tyr-nitrated proteins are preferentially degraded by proteasomes, and this may explain why the radiation-stimulated protein Tyr nitration is transient (10). There is no definitive molecular evidence for mammalian denitrases (11, 12).

The significance of Tyr nitration may lie more as being diagnostic for ONOO- formation. Although high concentrations of ONOO- can cause specific DNA base lesions, ONOO- is highly unstable and mostly isomerizes to relatively innocuous nitrates and nitrites (19). Wink et al. (13) propose that this is a mechanism by which NO protects cells from oxidative DNA damage caused by O<UP><SUB>2</SUB><SUP>&cjs1138;</SUP></UP> and H2O2.

The uniqueness of NO as a redox signaling molecule resides in part in its relative stability and hydrophobic properties that permit its diffusion across cell membranes over several cell diameter distances (19). The present study demonstrating radiation-stimulated NO generation suggests mechanisms by which an ionization event in one cell can be sensed in neighboring cells. This may have significance not only for radiotherapy but may represent one mechanism by which cells sense and initiate trans-cellular signaling critical for tissues in responding to localized oxidative events, e.g. metabolic ROS generation, hypoxia, or low level environmental radiation.

    FOOTNOTES

* This work was supported in part by United States Public Health Service Grants CA65896, CA72955, and 5T32DK07150, developmental funds from the Massey Cancer Center, and a generous gift from Tanya Gordon.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Present address: Division of Bioengineering and Environmental Health, Massachusetts Institute of Technology, Boston MA 02139.

|| Supported by United States Public Health Service Grants HL60190 and HD398110.

** To whom correspondence should be addressed. Tel.: 804-628-0857; Fax: 804-828-6042; E-mail: rmikkels@vcu.edu.

Published, JBC Papers in Press, February 20, 2002, DOI 10.1074/jbc.M110309200

2 R. B. Mikkelsen, unpublished data.

    ABBREVIATIONS

The abbreviations used are: ERK1/2, extracellular signal-regulated kinase 1/2; DCF, dichlorofluorescein; L-NAME, L-NG-nitroarginine methyl ester; L-NMMA, L-NG-monomethylarginine; MnTBAP, Mn (III)tetrakis (4-benzoic acid) porphyrin; NOS, nitric-oxide synthase; ONOO-, peroxynitrite; PKG, protein kinase G; RNS, reactive nitrogen species; ROS, reactive oxygen species; sGC, soluble guanylate cyclase; SOD, superoxide dismutase; O<UP><SUB>2</SUB><SUP>&cjs1138;</SUP></UP>, superoxide anion; CHO, Chinese hamster ovary; Gy, gray; ELISA, enzyme-linked immunosorbent assay.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Todd, D., and Mikkelsen, R. B. (1994) Cancer Res. 54, 5224-5230[Abstract/Free Full Text]
2. Schmidt-Ullrich, R., Dent, P., Grant, S., Mikkelsen, R. B., and Valerie, K. (2000) Radiat. Res. 153, 245-257[Medline] [Order article via Infotrieve]
3. Stephenson, M. A., Pollock, S., Coleman, N. C., and Calderwood, S. (1994) Cancer Res. 54, 12-15[Abstract/Free Full Text]
4. Kharbanda, S., Yuan, Z.-M., Rubin, E., Weichselbaum, R., and Kufe, D. (1994) J. Biol. Chem. 269, 20739-20743[Abstract/Free Full Text]
5. Kharbanda, S., Saleem, A., Shafman, T., Emoto, Y., Weichselbaum, R., and Kufe, D. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 5416-5420[Abstract/Free Full Text]
6. Kasid, U., Suy, S., Dent, P., Ray, S., Whiteside, T. L., and Sturgill, T. W. (1996) Nature 382, 813-816[CrossRef][Medline] [Order article via Infotrieve]
7. Kavanagh, B. D., Dent, P., Schmidt-Ullrich, R. K., Chen, P., and Mikkelsen, R. B. (1998) Radiat. Res. 149, 579-587[Medline] [Order article via Infotrieve]
8. Haimovitz-Friedman, A., Kan, C.-C., Ehleiter, D., Persaud, R., McLaughlin, M., Fuks, Z., and Kolesnick, R. (1994) J. Exp. Med. 180, 525-535[Abstract/Free Full Text]
9. Yamakura, F., Taka, H., Fujimura, T., and Murayama, K. (1998) J. Biol. Chem. 273, 14085-14089[Abstract/Free Full Text]
10. Gow, A. J., Duran, D., Malcolm, S., and Ischiropoulos, H. (1996) FEBS Lett. 385, 63-66[CrossRef][Medline] [Order article via Infotrieve]
11. Kamisaki, Y., Wada, K., Bian, K., Balbanli, B., Davis, K., Martin, E., Behbod, F., Lee, Y., and Murad, F. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 11584-11589[Abstract/Free Full Text]
12. Kuo, W.-N., Kanadia, R., Shanbhag, V. P., and Toro, R. (1999) Mol. Cell. Biochem. 201, 11-16[CrossRef][Medline] [Order article via Infotrieve]
13. Wink, D. A., Hanbauer, I., Krishna, M. C., DeGraff, M. C., Gamson, W., and Mitchell, J. B. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 9813-9817[Abstract/Free Full Text]
14. Ward, J. (1994) Radiat. Res. 138, S85-S88[Medline] [Order article via Infotrieve]
15. Leach, J., Van Tuyle, G., Lin, P.-S., Schmidt-Ullrich, R., and Mikkelsen, R. B. (2001) Cancer Res. 61, 3894-3901[Abstract/Free Full Text]
16. Narayanan, P., Goodwin, E., and Lehnert, B. (1997) Cancer Res. 57, 3963-3971[Abstract/Free Full Text]
17. Clutton, S., Townsend, K., Walker, C., Ansell, J., and Wright, E. (1996) Carcinogenesis 17, 1633-1639[Abstract/Free Full Text]
18. Zorov, D. B., Filburn, C. R., Klotz, L. O., Zweier, J. L., and Sollott, S. J. (2000) J. Exp. Med. 192, 1001-1014[Abstract/Free Full Text]
19. Beckman, J. S., and Koppenol, W. H. (1996) Am. J. Physiol. 271, C1424-C1437[Abstract/Free Full Text]
20. Goda, N., Suematsu, M., Mukai, M., Kiyokawa, K., Natori, M., Nozawa, S., and Ishimura, Y. (1997) Am. J. Physiol. 271, H1893-H1899
21. Janssen, M. Y. W., Soultanakis, R., Steece, K., Heerdt, E., Singh, R. J., Joseph, J., and Kalyanaraman, B. (1998) Am. J. Physiol. 275, L1100-L1109[Abstract/Free Full Text]
22. Niu, X. F., Ibbotson, G., and Kubes, P. (1996) Circ. Res. 79, 992-999[Abstract/Free Full Text]
23. Balazy, M., Kaminski, P. W., Mao, K., Tan, J., and Wolin, M. S. (1998) J. Biol. Chem. 273, 32009-32015[Abstract/Free Full Text]
24. Ducrocq, C., Blanchard, B., Pignatelli, B., and Ohshima, H. (1999) Cell. Mol. Life Sci. 55, 1068-1077[CrossRef][Medline] [Order article via Infotrieve]
25. Ibuki, Y., and Goto, A. (1997) Free Radic. Biol. Med. 22, 1029-1035[CrossRef][Medline] [Order article via Infotrieve]
26. Janssens, M. Y., Van den Berge, D. L., Verovski, V. N., Monsaert, C., and Storme, G. A. (1998) Cancer Res. 58, 5646-5648[Abstract/Free Full Text]
27. MacMillan-Crow, L. A., Crow, J. P., Kerby, J. D., Beckman, J. S., and Thompson, J. A. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 11853-11858[Abstract/Free Full Text]
28. Stuehr, D. (1999) Biochim. Biophys. Acta 1411, 217-230[Medline] [Order article via Infotrieve]
29. Phung, Y. T., and Black, S. M. (1999) IUBMB Life 48, 333-338[Medline] [Order article via Infotrieve]
30. Yuen, P. S., Doolittle, L. K., and Garbers, D. L. (1994) J. Biol. Chem. 269, 791-793[Abstract/Free Full Text]
31. Lopez, F., Esteve, J. P., Buscail, L., Delesque, N., Saint-Laurent, N., Theveniau, M., Nahmias, C., Vaysse, N., and Susini, C. (1997) J. Biol. Chem. 272, 24448-24454[Abstract/Free Full Text]
32. Yamauchi, K., Milarski, K. L., Saltiel, A. R., and Pessin, J. E. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 664-668[Abstract/Free Full Text]
33. Miranda, S., Foncea, R., Guerrero, J., and Leighton, F. (1999) Biochem. Biophys. Res. Commun. 258, 44-49[CrossRef][Medline] [Order article via Infotrieve]
34. Crow, J. P. (1997) Nitric Oxide 1, 145-157[CrossRef][Medline] [Order article via Infotrieve]
35. Possel, H., Noack, H., Augustin, W., Keilhoff, G., and Wolf, G. (1997) FEBS Lett. 416, 175-178[CrossRef][Medline] [Order article via Infotrieve]
36. Cordelier, P., Esteve, J. P., Rivard, N., Marletta, M., Vaysse, N., Susini, C., and Buscail, L. (1999) FASEB J. 13, 2037-2050[Abstract/Free Full Text]
37. Bonner, J. A., Vroman, B. T., Christianson, T. J. H., and Karnitz, L. M. (1998) Int. J. Radiat. Oncol. Biol. Phys. 42, 921-925[CrossRef][Medline] [Order article via Infotrieve]
38. Morales, A., Miranda, M., Sanchez-Reyes, A., Biete, A., and Fernandez-Checa, J. (1998) Int. J. Radiat. Oncol. Biol. Phys. 42, 191-204[CrossRef][Medline] [Order article via Infotrieve]
39. Kanai, A. J., Pearce, L. L., Clemens, P. R., Birder, L. A., VanBibber, M. M., Choi, S. Y., de Groat, W. C., and Peterson, J. (2001) Proc. Natl. Acad. Sci. U. S. A. 98, 14126-14131[Abstract/Free Full Text]
40. Barrett, W. C., DeGnore, J. P., Keng, Y. F., Zhang, Z.-Y., Yim, Y. B., and Chock, P. B. (1999) J. Biol. Chem. 274, 34543-34546[Abstract/Free Full Text]
41. Stamler, J. S., Lipton, S. A., and Sucher, N. J. (1997) Neuron 18, 691-696[CrossRef][Medline] [Order article via Infotrieve]
42. Marshall, H. E., Merchant, K., and Stamler, J. S. (2000) FASEB J. 14, 1889-1900[Abstract/Free Full Text]
43. Zhou, X.-B., Ruth, P., Schlossmann, J., Hofmann, F., and Korth, M. (1996) J. Biol. Chem. 271, 19760-19767[Abstract/Free Full Text]
44. Becker, E. M., Wunder, F., Kast, R., Robyr, C., Hoenicka, M., Gerzer, R., Schroder, H., and Stasch, J. P. (1999) Nitric Oxide 3, 55-66[CrossRef][Medline] [Order article via Infotrieve]
45. Komalavilas, P., Shah, P. K., Jo, H., and Lincoln, T. M. (1999) J. Biol. Chem. 274, 34301-34309[Abstract/Free Full Text]
46. Gudi, T., Huvar, I., Meinecke, M., Lohmann, S. M., Boss, G. R., and Pilz, R. B. (1996) J. Biol. Chem. 271, 4597-4600[Abstract/Free Full Text]
47. Chiche, J.-D., Schlutsmeyer, S. M., Block, D. B., de la Monte, S. M., Roberts, J. D., Filippov, G., Janssens, S. P., Rosenzweig, A., and Bloch, K. D. (1998) J. Biol. Chem. 273, 34263-34271[Abstract/Free Full Text]
48. Browning, D., McShane, M. P., Marty, C., and Ye, R. D. (2000) J. Biol. Chem. 275, 2811-2816[Abstract/Free Full Text]
49. Suhasini, M., Li, H., Lohmann, S. M., Boss, G. R., and Pilz, R. B. (1998) Mol. Cell. Biol. 18, 6983-6994[Abstract/Free Full Text]
50. Gu, M., Lynch, J., and Brecker, P. (2000) J. Biol. Chem. 275, 11389-11396[Abstract/Free Full Text]
51. Collins, S. P., and Uhler, M. (1999) J. Biol. Chem. 274, 8391-8404[Abstract/Free Full Text]
52. Deora, A. A., Hajjar, D., and Lander, H. (2000) Biochemistry 39, 9901-9908[CrossRef][Medline] [Order article via Infotrieve]
53. Lander, H. M., Ogiste, J. S., Teng, K. K., and Novogrodsky, A. (1995) J. Biol. Chem. 270, 21195-21198[Abstract/Free Full Text]
54. Tonks, N. K., and Neel, B. G. (1996) Cell 87, 365-368[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
J. S. Isenberg, J. B. Maxhimer, F. Hyodo, M. L. Pendrak, L. A. Ridnour, W. G. DeGraff, M. Tsokos, D. A. Wink, and D. D. Roberts
Thrombospondin-1 and CD47 Limit Cell and Tissue Survival of Radiation Injury
Am. J. Pathol., October 1, 2008; 173(4): 1100 - 1112.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
H.-C. Lee, S. An, H. Lee, S.-H. Woo, H.-O. Jin, S.-K. Seo, T.-B. Choe, D.-H. Yoo, S.-J. Lee, Y.-J. Hong, et al.
Activation of Epidermal Growth Factor Receptor and Its Downstream Signaling Pathway by Nitric Oxide in Response to Ionizing Radiation
Mol. Cancer Res., June 1, 2008; 6(6): 996 - 1002.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Radiol.Home page
W Han, L Wu, B Hu, L Zhang, S Chen, L Bao, Y Zhao, A Xu, and Z Yu
The early and initiation processes of radiation-induced bystander effects involved in the induction of DNA double strand breaks in non-irradiated cultures
Br. J. Radiol., September 1, 2007; 80(Special_Issue_1): S7 - S12.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Radiol.Home page
W Zhao, D I Diz, and M E Robbins
Oxidative damage pathways in relation to normal tissue injury
Br. J. Radiol., September 1, 2007; 80(Special_Issue_1): S23 - S31.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.